ICON offers central laboratory testing and biomark
Post# of 30028
"This agreement represents a major milestone for Amarantus, as we can now prepare LymPro for launch with a top-tier commercial development organization with the required CLIA capabilities as the backbone for launch in the United States and abroad," - GC
Why would we partner with only 1 big BP? If we partner with ICON and LymPro is able to what everyone is expecting, then it will back every other BP into a corner to have to use LymPro. Or it will push one BP to buy it and keep for themselves.
A BP will want to keep it out if the hands of any competition, no? No way, would they let other BP use it in order to help find a cure for ALZ before themselves.